Urinary nanovesicles captured by lectins or antibodies demonstrate variations in size and surface glycosylation profile. (June 2017)

• Record Type: Journal Article
• Authors: Gerlach, Jared Q; Maguire, Ciaran M; Krüger, Anja; Joshi, Lokesh; Prina-Mello, Adriele; Griffin, Matthew D
• Is Part Of: Nanomedicine. Volume 12:Number 11(2017)
• Page Start: 1217
• Page End: 1229
• Publication Date: 2017-06
• Subjects: capture -- exosome -- extracellular vesicle -- glycosylation -- isolation -- lectin -- nanotracking analysis -- precipitation -- urine; Nanotechnology -- Periodicals; Medical technology -- Periodicals; Nanotechnology -- Therapeutic use -- Periodicals; 610.28
• DOI: 10.2217/nnm-2017-0016
• Languages: English
• ISSNs: 1743-5889

Abstract

Aim: The use of carbohydrate-binding proteins (lectins) to isolate urinary extracellular vesicles (uEVs) was investigated and the captured subpopulations were characterized.Methods: Pooled uEVs from multiple healthy donors were exposed to lectin-conjugated or antibody-conjugated beads. Recovered uEVs were evaluated by protein estimation, transmission electron microscopy, nanoparticle tracking analysis and lectin microarray profiling.Results: uEVs isolated by lectin- and antibody-based affinity capture exhibited distinct variations in size and surface content. Transmission electron microscopy confirmed similar EV diameters to those established by nanoparticle tracking analysis, but total particle counts did not correlate closely with protein-based quantification. Lectin microarray profiling demonstrated capture-dependent differences in surface glycosylation.Conclusion: Selective, carbohydrate-mediated EV isolation by lectin affinity approaches may prove immediately useful for research and find eventual use in clinical applications.